Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Kong Garheng, Director. Officer active across 6 companies, notably Strongbridge Biopharma plc. Cumulatively, 23 reports have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €3.6m. Activity tracked since 14 May 2021. The latest transaction was disclosed on 5 June 2024 (Attribution). Regulator: SEC (Form 4). All data is free.